Quick Dispatch:
Your retatrutide clinical trial data VisualAbstract: Retatrutide reduces body weight by 17.5% in patients with obesity orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your retatrutide clinical trial data VisualAbstract: Retatrutide reduces body weight by 17.5% in patients with obesity ships.
Need Help?
Questions about retatrutide clinical trial data VisualAbstract: Retatrutide reduces body weight by 17.5% in patients with obesity, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for retatrutide clinical trial data VisualAbstract: Retatrutide reduces body weight by 17.5% in patients with obesity in your area.
Lilly's triple agonist delivers up to 71.2 lbs of weight loss
26.69
Retatrutide Before and After: Doctor Reveals Real Results
29.85
Eli Lilly infiltrates anti-obesity market as Phase III trial for retatrutide begins
21.73
Clinical trials of subcutaneous tirzepatide, retatrutide, and
28.47
New Phase 3 retatrutide data just dropped 👀 Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats: •
26.08
Retatrutide, an Amazing Future for Weight Loss
23.14
Today we shared new results on retatrutide, an investigational, first-of-its-kind treatment we're studying in adults with obesity or overweight with at least one weight-related comorbidity. Read more about the Phase 3 findings:
22.80
